Chemoembolization versus chemotherapy in elderly patients with unresectable hepatocellular carcinoma and contrast uptake as prognostic factor

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 52, Issue 5, 1997, Pages

  Biselli, Maurizio ^a   Forti, Paola ^b   Mucci, Fabrizio ^a   Foschi, Francesco Giuseppe ^a   Marsigli, Lorenzo ^b   Caputo, Fabio ^a   Ravaglia, Giovanni ^b   Bernardi, Mauro ^a   Stefanini, Giuseppe Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DOXORUBICIN; IODINATED POPPYSEED OIL;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; ELDERLY CARE; FEMALE; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0030767759     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/52A.5.M305     Document Type: Article

References (25)

1. Simonetti RG, Cammà C, Fiorello F, Politi F, D'Amico G, Pagliaro L. Hepatocellular carcinoma: a worldwide problem and major risk factor. Dig Dis Sci 1991;36:962-72.
2. Nzeako UC, Goodman ZD, Ishak KG. Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 1995;76:579-88.
3. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-22.
4. Trevisani F, D'Intino PE, Grazi GL, et al. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 1996;77:2223-32.
5. Gozzetti G, Mazziotti A, Cavallari A, et al. Hepatic resection for tumors in cirrhotic livers. Intern Surg 1987;72:82-6.
6. Pichlmayer R. Is there a place for liver grafting for malignancy? Transplant Proc 1988;20:478-82.
7. Akashi Y, Koreeda C, Enomoto S, et al. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 1991;14:262-8.
8. Sutton FM, Russel NC, Guinee VF, Alpert E. Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol 1988;6:321-8.
9. Colombo M. Treatment of hepatocellular carcinoma. Ital J Gastroenterol 1994;26:242-6.
10. Schwartz ME. Primary hepatocellular carcinoma: transplant versus resection. Semin Liver Dis 1994;14:135-9.
11. Kanemastu T, Furuta T, Takenaka K, et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989;10:98-102.
12. Vetter D, Wenger JJ, Bergier JM, Doffoel M, Bockel R. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a western comparative study in 60 patients. Hepatology 1991;13:427-33.
13. Bruneton JN, Kerboul P, Grimaldi C, et al. Hepatic intraarterial lipiodol and CT of hepatic tumors: diagnostic and therapeutic value. Radiology 1985;157:313.
14. Dusheiko GM, Hobbs KEF, Dick R, Burroughs AK. Treatment of small hepatocellular carcinomas. Lancet 1992;340:285-8.
15. Okuda K, Peters RL, Simson IW. Gross anatomical features of hepatocellular carcinoma from three disparate geographic areas: proposal of new classification. Cancer 1984;54:2165-73.
16. Stefanini GF, Amorati P, Biselli M, et al. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer 1995;75:2427-34.
17. Higashi S, Shimizu M, Nakashima T, et al. Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Cancer 1995;75:1245-54.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
20. Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992;163:387-94.
21. Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M. Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol 1990;13:135-9.
22. Groupe d'etude et de traitement du carcinome hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-61.
23. Yamada R, Sato M, Kawabata M, Nakatsuka N, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401.
24. Hao XY, Bergh J, Brodin O, Hellman U, Mannervik B. Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer line is correlated to elevated expression of glutathione-linked detoxification enzymes. Carcinogenesis 1994;15:1167-73.
25. Kantarjian HM, O'Brien S, Smith T, et al. Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen. Br J Haematol 1994;88:94-100.